HTG MOLECULAR DIAGNOSTICS, INC Business Operations Contracts & Agreements
16 Contracts & Agreements
- Development Agreements (12 contracts)
- Sales Agreements (2)
- Supply Agreements (1)
- Termination Agreements (1)
- Controlled Equity OfferingSM Sales Agreement, dated as of November 14, 2019, by and between HTG Molecular Diagnostics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 15, 2019)
- First Amendment to Amended and Restated IVD Test Development and Component Supply Agreement, dated April 23, 2019, by and between Illumina, Inc. and the Registrant (Filed With SEC on May 9, 2019)
- Fourth Amendment to Statement of Work No. 2, dated February 15, 2019, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and... (Filed With SEC on May 9, 2019)
- Sales Agreement, dated as of March 13, 2019, by and between HTG Molecular Diagnostics, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)
- First Amendment to Statement of Work No. 3, dated September 21, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and... (Filed With SEC on November 8, 2018)
- Third Amendment to Statement of Work No. 2, dated September 27, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and... (Filed With SEC on November 8, 2018)
- Second Amendment to Statement of Work No. 2, dated August 13, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN... (Filed With SEC on November 8, 2018)
- First Amendment to Statement of Work No. 2, dated August 7, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN... (Filed With SEC on November 8, 2018)
- Statement of Work No. 3, dated January 12, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN Manchester Limited (Filed With SEC on May 10, 2018)
- Statement of Work No. 2, dated October 26, 2017, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN Manchester Limited (Filed With SEC on March 23, 2018)
- Amendment to Statement of Work No. 1, dated December 18, 2017, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN... (Filed With SEC on March 23, 2018)
- First Amendment to Master Assay Development, Commercialization and Manufacturing Agreement (Filed With SEC on August 8, 2017)
- AMENDED AND RESTATED IVD TEST development AND COMPONENT SUPPLY AGREEMENT (Filed With SEC on August 8, 2017)
- Master Assay Development, Commercialization and Manufacturing Agreement (Filed With SEC on March 23, 2017)
- IVD TESTDEVELOPMENT AND COMPONENT SUPPLY AGREEMENT (Filed With SEC on December 30, 2014)
- TERMINATION OF SECURITY AGREEMENT, RELEASE OF SECURITY INTEREST AND UNDERSTANDING REGARDING ASSET PURCHASE AGREEMENT (Filed With SEC on December 30, 2014)
